Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study

被引：0

作者：

Dirix, L. Y.

Romieu, G.

Provencher, L.

Grimes, D.

de Souzo, Viana L.

Paterson, A.

Mauriac, L.

Kirsch, A.

Pernas, S.

Miles, D. W.

机构：

[1] Oncol Ctr AZ St Augustinus Oncol, Antwerp, Belgium

[2] CRLCC Val Aurelle, Montpellier, France

[3] Hop St Sacrement, Quebec City, PQ, Canada

[4] Brisbane Haematol Oncol Clin, Auchenflower, Australia

[5] Hosp Canc Barretos, Barretos, Brazil

[6] Tom Baker Canc Clin, Calgary, AB, Canada

[7] Inst Bergonie, Bordeaux, France

[8] Onkol Schwerpunki Oskar Helene Heim, Berlin, Germany

[9] Inst Catala Oncol, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：285S / 285S

页数：1